Evidence Hub

The impact of the COVID-19 pandemic on nosocomial infections and antimicrobial resistance (AMR) in intensive care units

Bennis L, Elouardi Y, El Aarabi H, Oussayeh I, Khallouki M

New microbes and new infections, 2025

187 participants · 1 citation

Abstract

The COVID-19 pandemic may have influenced healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), particularly in intensive care units (ICUs). We performed a retrospective study in the ICU of Ibn Tofail Hospital, Marrakech, Morocco from March to September 2022. Patients hospitalized for more than 48 h were included. HAIs were defined according to CDC criteria, and antimicrobial susceptibility testing followed EUCAST guidelines. Results were compared with pre-pandemic data from 2019. Of 187 admitted patients, 145 were eligible, and 38 developed an HAI (26.3 %). The most frequent infections were pneumonia (37 %), catheter-related infections (27.5 %), and urinary tract infections (16.1 %). Among 112 isolates, Gram-negative bacteria predominated (82.7 %), mainly Klebsiella pneumoniae (26.8 %), Acinetobacter baumannii (17.9 %), and Pseudomonas aeruginosa (14.3 %). Compared with 2019 (98 isolates), K. pneumoniae increased significantly (17.3 % vs. 26.8 %, p = 0.048). Resistance to ceftazidime rose in P. aeruginosa (22.2 % vs. 56.3 %, p = 0.042), while methicillin resistance in Staphylococcus aureus declined (75.0 % vs. 25.0 %, p = 0.044). No significant changes were observed in carbapenem resistance. Multidrug resistance remained widespread (45.9 % vs. 50.9 %, p = 0.458). HAIs in this ICU were mainly due to Gram-negative bacteria, with notable shifts in K. pneumoniae prevalence and specific resistance patterns after the pandemic. While multidrug resistance…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free